Medivisor India Treatment LLP
About Medivisor India Treatment LLP
Data last updated:
Medivisor India Treatment LLP is a limited liability partnership (LLP) based in Delhi, India. It operates in the service-based operations segment of the business services sector. It was incorporated on 21 September 2015 and has been in existence for over 11 years.
The LLP is registered with the Registrar of Companies (ROC), Delhi, under LLPIN AAE-7817. Its GSTIN is 07AAKFT6252H1ZX (Delhi). The LLP holds 2 GST registrations, all of them active.
The LLP has a total obligation of contribution of ₹20,000. It is led by designated partners Tanuja Kumari and Kumar Sushant.
Its latest statement of accounts is for the year ended 31 March 2025. The registered office is at Hno – F – 1/60 F/F Gali No – 2, Sundar Nagar Near Hari Om Shiv Mandir, Delhi, India – 110093.
As per the financials filed for FY 2022, the LLP reported a revenue of ₹64.41 Lakh. For the same year it recorded a net profit of ₹4.14 Lakh (net margin 6.4%) and EBITDA of ₹7.66 Lakh (EBITDA margin 11.9%). Revenue has grown at a compounded annual rate (CAGR) of 9% over three years and 14% over five years.
As per MCA filings, the LLP has open charges of ₹1.75 Cr on record. Court records list 1 case involving the LLP, including 1 filed against it.
Company details
Contact details
Medivisor India Treatment LLP's registered office is in Delhi, Delhi. Its e-mail address is in the company report.
- Email
- Registered AddressHno – F – 1/60 F/F Gali No – 2, Sundar Nagar Near Hari Om Shiv Mandir, Delhi, India – 110093
- IndustryBusiness Services, Other Services
To see the full contact details of Medivisor India Treatment LLP, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Medivisor India Treatment LLP
FY 2025 filings availableMedivisor India Treatment LLP reported revenue of ₹64.41 Lakh for FY 2022.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 14% over five years. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Statement of Account and Solvency | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Income and Expenditure | |||||
| Turnover | |||||
| Other Income | |||||
| Total Income | ₹64.41 Lakh | ||||
| Purchases and Direct Costs | |||||
| Personnel Expenses | |||||
| Administrative Expenses | |||||
| Interest | |||||
| Depreciation | |||||
| Total Expenses | |||||
| Profit Before Tax | |||||
| Tax | |||||
| Profit After Tax | ₹4.14 Lakh | ||||
| Profit Transferred to Partners | |||||
| Assets and Liabilities | |||||
| Partners' Contribution | |||||
| Reserves and Surplus | |||||
| Secured Loans | |||||
| Unsecured Loans | |||||
| Trade Payables | |||||
| Other Liabilities and Provisions | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Loans and Advances | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Statement of Account and Solvency | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profitability | |||||
| Net Profit Margin | 6.4% | ||||
| Return on Partners' Funds | |||||
| Return on Assets | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Debt to Partners' Funds | |||||
| Interest Coverage | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Turnover Growth | |||||
| Profit Growth | |||||
To see the full financial statements and ratios of Medivisor India Treatment LLP, buy the company report.
Designated partners of Medivisor India Treatment LLP
Medivisor India Treatment has 2 designated partners on record. No former designated partners are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Tanuja Kumari Also directs: Medivisor Overseas Treatment LLP, Medivisor Overseas Studies LLP, Medivisor Homes LLP and 1 more | Designated Partner | 21 Sep 2015 | 11 Years 1 Months | Current |
| Kumar Sushant Also directs: Medivisor Overseas Treatment LLP, Medivisor Overseas Studies LLP, Medivisor Homes LLP and 1 more | Designated Partner | 21 Sep 2015 | 11 Years 1 Months | Current |
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 30 Sep 2022 | 100625992 | Housing Development Finance Corporation Limited | ₹1.75 Cr | Open |
Total charge records: 1 View all charges
Legal cases
Medivisor India Treatment LLP has 1 court case on record: 1 filed against it. All case is disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 1 | 1 | 0 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Shahdara, Delhi | Civil suit | Filed against the company by State | Disposed |
To see the full case history of Medivisor India Treatment LLP, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Medivisor India Treatment LLP; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Medivisor India Treatment has 2 GST registrations: 2 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AAKFT6252H1ZX | Delhi | Active | 01 Jul 2017 |
| 09AAKFT6252H1ZT | Uttar Pradesh | Active | 18 Feb 2022 |
To see the full GST registrations and return filing status of Medivisor India Treatment LLP, buy the company report.
Recent activity
Medivisor India Treatment LLP has 2 designated partner changes on record since 2015: 2 appointments. The latest: Kumar Sushant was appointed as Designated Partner on 21 Sep 2015.
Frequently asked questions
Medivisor India Treatment is an active limited liability partnership based in Delhi, India. The LLP works in other services, within the business services industry. It was incorporated on 21 September 2015 (11+ years old) and is registered under LLPIN AAE-7817.
Medivisor India Treatment has 2 current designated partners:
- Tanuja Kumari - Designated Partner
- Kumar Sushant - Designated Partner
The latest financial statements of Medivisor India Treatment on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 31 March 2025. Year-wise statements from FY 2016 are in the company report.
The GSTIN of Medivisor India Treatment is 07AAKFT6252H1ZX, registered in Delhi. The LLP has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 09AAKFT6252H1ZT (Uttar Pradesh).
The LLPIN (Limited Liability Partnership Identification Number) of Medivisor India Treatment is AAE-7817. It is issued by the Ministry of Corporate Affairs and uniquely identifies the LLP in India.
Medivisor India Treatment has 1 court case on record: 1 filed against it.
Medivisor India Treatment was incorporated on 21 September 2015, making it 11+ years old. It is registered with the Registrar of Companies, Delhi.
Kumar Sushant was appointed as Designated Partner on 21 Sep 2015. Tanuja Kumari was appointed as Designated Partner on 21 Sep 2015.
The registered office of Medivisor India Treatment is at Hno – F – 160 FF Gali No – 2, Sundar Nagar Near Hari Om Shiv Mandir, Delhi, India – 110093.
Medivisor India Treatment operates in the business services industry, in the other services segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
